- Home
- UPXI vs TOI Comparison
UPXI vs TOI Comparison
Compare UPXI & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- TOI
- Stock Information
- Founded
- UPXI 2018
- TOI 2007
- Country
- UPXI United States
- TOI United States
- Employees
- UPXI N/A
- TOI N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- TOI Medical/Nursing Services
- Sector
- UPXI Health Care
- TOI Health Care
- Exchange
- UPXI Nasdaq
- TOI Nasdaq
- Market Cap
- UPXI 481.8M
- TOI 444.1M
- IPO Year
- UPXI 2021
- TOI N/A
- Fundamental
- Price
- UPXI $3.31
- TOI $3.50
- Analyst Decision
- UPXI
- TOI Strong Buy
- Analyst Count
- UPXI 0
- TOI 2
- Target Price
- UPXI N/A
- TOI $6.50
- AVG Volume (30 Days)
- UPXI 4.0M
- TOI 2.3M
- Earning Date
- UPXI 11-11-2025
- TOI 11-13-2025
- Dividend Yield
- UPXI N/A
- TOI N/A
- EPS Growth
- UPXI N/A
- TOI N/A
- EPS
- UPXI N/A
- TOI N/A
- Revenue
- UPXI $15,811,345.00
- TOI $424,376,000.00
- Revenue This Year
- UPXI $145.75
- TOI $21.71
- Revenue Next Year
- UPXI N/A
- TOI $20.58
- P/E Ratio
- UPXI N/A
- TOI N/A
- Revenue Growth
- UPXI N/A
- TOI 17.53
- 52 Week Low
- UPXI $1.90
- TOI $0.13
- 52 Week High
- UPXI $22.57
- TOI $4.88
- Technical
- Relative Strength Index (RSI)
- UPXI 29.09
- TOI 34.96
- Support Level
- UPXI $3.44
- TOI $4.49
- Resistance Level
- UPXI $5.25
- TOI $4.62
- Average True Range (ATR)
- UPXI 0.37
- TOI 0.31
- MACD
- UPXI -0.13
- TOI -0.12
- Stochastic Oscillator
- UPXI 12.55
- TOI 10.82
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.